123 related articles for article (PubMed ID: 10351956)
1. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population.
Hizawa N; Yamaguchi E; Furuya K; Jinushi E; Ito A; Kawakami Y
Am J Respir Crit Care Med; 1999 Jun; 159(6):2021-3. PubMed ID: 10351956
[TBL] [Abstract][Full Text] [Related]
2. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.
Petrek M; Drábek J; Kolek V; Zlámal J; Welsh KI; Bunce M; Weigl E; Du Bois R
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1000-3. PubMed ID: 10988120
[TBL] [Abstract][Full Text] [Related]
3. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
[TBL] [Abstract][Full Text] [Related]
4. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
5. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
6. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
7. Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I alleles) in the Polish population.
Lewandowska M; Franciszkiewicz K; Prokop J; Ofori H; Jagodzinski PP
J Hum Genet; 2002; 47(11):585-9. PubMed ID: 12436194
[TBL] [Abstract][Full Text] [Related]
8. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis.
Miyagishi R; Niino M; Fukazawa T; Yabe I; Kikuchi S; Tashiro K
J Neuroimmunol; 2003 Dec; 145(1-2):135-8. PubMed ID: 14644039
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
10. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis.
Valentonyte R; Hampe J; Croucher PJ; Müller-Quernheim J; Schwinger E; Schreiber S; Schürmann M
Am J Respir Crit Care Med; 2005 May; 171(10):1136-41. PubMed ID: 15750046
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
12. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
[TBL] [Abstract][Full Text] [Related]
13. CCR2 allele polymorphisms in 15 Chinese ethnic populations.
Zhang XL; Zhang CY; Yu Y; Chen F; Li P; Fu SB
Int J Immunogenet; 2006 Feb; 33(1):45-8. PubMed ID: 16426243
[TBL] [Abstract][Full Text] [Related]
14. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
15. Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in North India.
Kaur G; Singh P; Kumar N; Rapthap CC; Sharma G; Vajpayee M; Wig N; Sharma SK; Mehra NK
Int J Immunogenet; 2007 Jun; 34(3):153-6. PubMed ID: 17504503
[TBL] [Abstract][Full Text] [Related]
16. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
[TBL] [Abstract][Full Text] [Related]
18. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
[TBL] [Abstract][Full Text] [Related]
19. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
20. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
